Navigation Links
Role of hormones, potential new treatments topic of UH lecture
Date:9/7/2012

While estrogen is essential for many of the body's normal processes in both men and women, it also plays a role in diseases such as breast, ovarian and prostate cancer. The impact of this hormone on such diseases will be addressed during a lecture Sept. 25 at the University of Houston (UH).

Dr. Jan-ke Gustafsson, biochemistry professor and director of the Center for Nuclear Receptors and Cell Signaling at UH, will present "Hormones in Health and Disease." He will be the third speaker in a UH lecture series highlighting the impact of science on health and society.

The lecture will focus on the discovery and functions of estrogen receptor beta (ERbeta) and its impact on drug delivery and disease. A steroid hormone found in both males and females, estrogen binds to and activates the estrogen receptors, triggering the regulation of gene expression.

In 1995, Gustafsson and his research group discovered there are two estrogen receptors instead of one. The discovery of ERbeta was a major and unexpected breakthrough. He is now proving the theories arising from that initial discovery. Due to its broad influence in the human body, ERbeta is a premier target for drug delivery and therapies.

"Estrogen and estrogen receptors are found in tissues ranging from the central nervous system, to breast tissue and the cardiovascular system," Gustafsson said. "ERbeta also regulates functions in the ovary, testis, prostate, kidney, bone and colon. Today, researchers are exploring the receptor as a target for drugs in treatments of neurological diseases, psychological disorders and cancer."

Sponsored by the College of Natural Sciences and Mathematics (NSM), the Friends of NSM Distinguished Lecture Series features leading scientists and physicians addressing breakthroughs in science that will alter the prevention, diagnosis and treatment of diseases, as well as impact the delivery of medical care. The lectures are free and open to the public.

WHO:

Jan-ke Gustafsson, M.D., Ph.D.

Robert A. Welch Professor of Chemistry

Director, Center for Nuclear Receptors and Cell Signaling at UH

WHAT:

Lecture: "Hormones in Health and Disease"

Friends of NSM Distinguished Lecture Series: Science Impacting Health and Society

WHEN:

7 8 p.m., Tuesday, Sept. 25

WHERE:

University of Houston
Rockwell Pavilion, second floor of the UH M.D. Anderson Library
Off Calhoun Road, Entrance 1
Map: http://www.friends.nsm.uh.edu/directions


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related medicine news :

1. PharmaNet system dramatically reduced inappropriate prescriptions of potentially addictive drugs
2. Cleveland Clinic researchers investigating potential drug for treatment of Alzheimers disease
3. US performs worst on potentially preventable death rates compared to France, Germany, and the UK
4. Could a cancer drug potentially prevent learning disabilities in some kids?
5. Earphones potentially as dangerous as noise from jet engines, according to new study
6. Diagnostic test shows potential to noninvasively identify significant coronary artery disease
7. CSI technology holds potential in everyday medicine
8. Potential new treatment target identified for melanoma skin cancer
9. Potential Nipah vaccine passes primate test
10. Researchers find potential cancer roadblock
11. Early treatment could mean greater earning potential for people with HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Role of hormones, potential new treatments topic of UH lecture
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... According ... with prostate cancer, including all stages, is more than 95%. Once the cancer spreads ... to less than 30%. To find out how to avoid this latter group, tune ...
(Date:3/27/2017)... Switzerland (PRWEB) , ... March 27, 2017 , ... ... food industry. Conventional sodium testing methods are complicated and require expert user knowledge. ... a new analytical method dedicated to the simplified, yet highly accurate, determination of ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow ... to resolve the pending litigation between itself and 1800 Vending DBA Healthy You ... , “I am thrilled to announce that we have now reached a settlement ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... with opioids alone responsible for over 33,000 of the 52,404 drug-related deaths in ... Bill (AB) 1512, which proposes a tax on prescription opioids to fund drug ...
(Date:3/27/2017)... ... March 27, 2017 , ... Harris Communications, Inc., a leading ... bringing its latest products to the Deaf Seniors of America Conference, April 4-7 at ... to meet with knowledgeable ASL friendly staff from Harris Communications and to try out ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  A recent study ... only four freestanding hospitals in the country dedicated to ... and reconstructive surgery, concluded that the Surfacide Helios ® ... integral component in reducing bacterial pathogens not killed by ... were published at the American Burn Association,s 49th Annual ...
(Date:3/27/2017)... 27, 2017 LightIntegra Technology Inc. today announced ... Dubiel as President and Chief Executive Officer effective March ... Board of Directors of LightIntegra. Paul Geyer ... LightIntegra. "This is the perfect time ... Executive Officer. We,ve selected a very strong leader at ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
Breaking Medicine Technology: